2024 American College of Rheumatology ( ACR ) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
Arthritis Care & Research · 2025-09 · 77 (9) · 1045-1065
DOI: 10.1002/acr.25528 ↗Kurz gefasst
Leitlinie in der Zeitschrift Arthritis Care & Research, online erschienen am 07.05.2025. Verfasst von Lisa R Sammaritano und 51 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Special Surgery - Weill Cornell Medicine, New York, New York. Hauptthemen laut MEDLINE: Lupus Nephritis, Rheumatology, Immunosuppressive Agents. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
Objective
The objective is to provide evidence‐based and expert guidance for the screening, treatment, and management of lupus nephritis.
Methods
The Core Team developed clinical questions for screening, treatment, and management of lupus nephritis using the PICO format (population, intervention, comparator, and outcome). Systematic literature reviews were completed for each PICO question, and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the quality of evidence and to formulate recommendations. The Voting Panel achieved a consensus ≥70% on the direction (for or against) and strength (strong or conditional) of each recommendation.
Results
We present 28 graded recommendations (7 strong, 21 conditional) and 13 ungraded, consensus‐based good practice statements for the screening and management of lupus nephritis. Our recommendations focus on the unifying principle that lupus nephritis therapy is continuous and ongoing, rather than consisting of discrete induction/initial and maintenance/subsequent therapies. Therapy should include pulse glucocorticoids followed by oral glucocorticoid taper and two additional immunosuppressive agents for 3–5 years for those achieving complete renal response.
Conclusion
This guideline provides direction for clinicians regarding screening and treatment decisions for management of lupus nephritis. These recommendations should not be used to limit or deny access to therapies, as treatment decisions may vary due to the unique clinical situation and personal preferences of each individual patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital for Special Surgery - Weill Cornell Medicine, New York, New York.
- Columbia University, New York, New York.
- UT Southwestern Medical Center, Dallas, Texas.
- University of California, San Francisco.
- Mayo Clinic, Rochester, Minnesota.
- The Hospital for Sick Children, Toronto, Ontario, Canada.
ORCID-Profile: Anca Askanase, Bonnie L Bermas, Alí Duarte-García, Linda T Hiraki, Brad H Rovin, Cynthia Aranow, April Barnado, Hermine I Brunner, Elizabeth D Ferucci, Aimee O Hersh, Benjamin J Smith, Daniel J Wallace, Christie M Bartels, Kimberly DeQuattro, Gabriel Figueroa-Parra, Shivani Garg, April Jorge, Shanthini Kasturi, Hassan Kawtharany, Kyriakos A Kirou, Megan M Lockwood, Alain Sanchez-Rodriguez, Jessica N Williams, Amy S Turner
Förderung
- NIAMS NIH HHS
Zitieren
APA
Sammaritano, L. R., Askanase, A., Bermas, B. L., Dall'Era, M., Duarte-García, A., Hiraki, L. T., Rovin, B. H., Son, M. B. F., Alvarado, A., Aranow, C., Barnado, A., Broder, A., Brunner, H. I., Chowdhary, V., Contreras, G., Felix, C., Ferucci, E. D., Gibson, K. L., Hersh, A. O., …, & Mustafa, R. A. (2025). 2024 American College of Rheumatology ( ACR ) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Care & Research, 77(9), 1045-1065. https://doi.org/10.1002/acr.25528
Vancouver
Sammaritano LR, Askanase A, Bermas BL, Dall'Era M, Duarte-García A, Hiraki LT, et al. 2024 American College of Rheumatology ( ACR ) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Care & Research. 2025;77(9):1045-1065. doi:10.1002/acr.25528
BibTeX
@article{Sammaritano2025,
author = {Sammaritano, Lisa R and Askanase, Anca and Bermas, Bonnie L and Dall'Era, Maria and Duarte-García, Alí and Hiraki, Linda T and Rovin, Brad H and Son, Mary Beth F and Alvarado, Anthony and Aranow, Cynthia and Barnado, April and Broder, Anna and Brunner, Hermine I and Chowdhary, Vaidehi and Contreras, Gabriel and Felix, Christele and Ferucci, Elizabeth D and Gibson, Keisha L and Hersh, Aimee O and Izmirly, Peter M and Kalunian, Kenneth and Kamen, Diane and Rollins, Brandi and Smith, Benjamin J and Thomas, Asha and Timlin, Homa and Wallace, Daniel J and Ward, Michael and Azzam, Muayad and Bartels, Christie M and Cunha, Joanne S and DeQuattro, Kimberly and Fava, Andrea and Figueroa-Parra, Gabriel and Garg, Shivani and Greco, Jessica and Cuéllar-Gutiérrez, Maria C and Iyer, Priyanka and Johannemann, Andrew S and Jorge, April and Kasturi, Shanthini and Kawtharany, Hassan and Khawandi, Jana and Kirou, Kyriakos A and Legge, Alexandra and Liang, Kelly V and Lockwood, Megan M and Sanchez-Rodriguez, Alain and Turgunbaev, Marat and Williams, Jessica N and Turner, Amy S and Mustafa, Reem A},
title = {2024 American College of Rheumatology ( ACR ) Guideline for the Screening, Treatment, and Management of Lupus Nephritis},
journal = {Arthritis Care & Research},
year = {2025},
volume = {77},
number = {9},
pages = {1045--1065},
doi = {10.1002/acr.25528}
}
EUVIMED